That’s right, companies great and small have the power to turnaround quickly…well maybe just their stocks do!
CRDC —robotic surgery wannabe play was up 30% on an upgrade. I told you not to short this stock! It can really run—no matter that it barely has any fundamentals—medical plays can get hot in a hurry. Stock has a nice base in the $7 range, can it breakout
and make an unreal cup and handle pattern at $15? TBD…
LDK —up nearly 29% on news of a 10-year contract, and they’re actually gonna get some money upfront! Woo hooo!! The stock has no doubled off its late November lows, but it’s still offs highs. I don’t know how to play this one—yes, it’s okay to not know—I’d like to short it, but it really only tanked on news of an internal investigation and those fears seem to have dissipated…I wouldn’t buy it here either, so let’s say avoid, for now…
NFI —here’s another big loser that’s recent beco0me a big winner. Coming off triple digits a year ago and now up 350% over its late November $1 share price range, this is one of those messy financial companies that everyone and their mother is suing and who knows how it’ll all turn out. AVOID FOREVER–IT’S A GUESSING GAME HERE
SORC —trading at 1/3 of its yearly highs, but now up 100% off its lows—the recent run up was ahead of earnings, the stock tanked on poor earnings, but today, it finished strong, maybe people are thinking all the negative news is priced in? Again, I have no idea how to play this one. Although it sounds strange, if you learn to avoid certain stocks / situations, your returns will improve.
JMBA —I covered this one last week, it’s off its lows and the run is continuing. I love it, keep it coming, the short squeeze is on, but lots of bitter shareholders will sell on any sign of a reversal.
AMPX —nearly $20 off their $25 yearly highs, this stock has now doubled in the past few days. Be careful shorting this one kids, it’s only a $20 million company, let the longs have their fun…for now.
RATE —wait a minute, this isn’t a big loser…oh wait, it’s tried and failed to break $54 four times in the past 2 years, it’s a small loser, better? The good news is the stock was up 22% today on an analyst upgrade so while it’s failed to breakout, it’s now also put in five nice bottoms in the $35 range. With a forward PE of 26 and a growth rate in the lows 20s, it’s fairly valued here, but this is a stock I’m going to buy on the $54 breakout—whenever it finally gets the courage to do that.
No positions
Posted in Uncategorized